Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / [email protected] ICP License: 琼ICP备2022009338号
TechFlow news, on August 5, biopharmaceutical company Silo Pharma (Nasdaq: SILO) today announced the launch of a cryptocurrency asset management strategy and appointed Corwin Yu, an expert in crypto infrastructure, as the first member of its cryptocurrency advisory committee. The strategy will focus on major digital assets such as Bitcoin, Ethereum, and SOL.
Biopharmaceutical company Silo Pharma (Nasdaq: SILO) today announced the launch of a cryptocurrency treasury strategy and appointed Corwin Yu, a crypto infrastructure expert, as the first member of its cryptocurrency advisory board. The strategy will focus on major digital assets such as Bitcoin, Ethereum, and SOL.
Navigating Web3 tides with focused insights
